Lenacapavir
ATC J05AX31 · 10 markets · 23 records
CA 4 records · 2 strengths
US 3 records · 2 strengths
- 300 mgtabletSunlencaYeztugo
- 50 mgtabletBIXLENVO
GB 2 records · 2 strengths
- 300 mgtabletSunlenca
- 463.5 mg/1.5 mLinjectionSunlenca 464mg/1.5ml solution for injection vials
AU 2 records · 1 strengths
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
ES 2 records · 2 strengths
MX 2 records · 2 strengths
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
TW 2 records · 2 strengths
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
HK 2 records · 1 strengths
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 2 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 2 records · 2 strengths
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | US | GB | CA | AU | ES | MX | TW | HK | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|
| 300 mg tablet | Sunlenca Yeztugo | Sunlenca | Sunlenca YEYTUO | Sunlenca | ||||||
| 309 mg liquid | Sunlenca YEYTUO | |||||||||
| 50 mg tablet | BIXLENVO | |||||||||
| 464 mg injection | Sunlenca | |||||||||
| 463.5 mg/1.5 mL injection | Sunlenca 464mg/1.5ml solution for injection vials | |||||||||
unknown | Sunlenca YEYTUO | Sunlenca Sunlenca solution for injection 463.5mg/1.5ml | Sunlenca YEYTUO | |||||||
tablet | Yeztugo | Sunlenca 尚能嘉膜衣錠 | SUNLENCA 300 mg, comprimé pelliculé | |||||||
injection | Sunlenca 尚能嘉注射劑 | SUNLENCA 464 mg, solution injectable | ||||||||
liquid | Yeztugo |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
4 more strength/form rows are recorded only in GB · AU · ES · MX · HK · EU and are not shown in this table. Hay 4 filas de concentración/forma registradas solo en GB · AU · ES · MX · HK · EU que no se muestran en esta tabla. 另有 4 个规格/剂型仅在 GB · AU · ES · MX · HK · EU 有记录(未在本表显示)。 另有 4 個規格/劑型僅在 GB · AU · ES · MX · HK · EU 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.